NOVAREX Co.Ltd (194700) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.041x

Based on the latest financial reports, NOVAREX Co.Ltd (194700) has a cash flow conversion efficiency ratio of 0.041x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.73 Billion ≈ $7.27 Million USD) by net assets (₩260.64 Billion ≈ $176.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 194700 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

NOVAREX Co.Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how NOVAREX Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NOVAREX Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NOVAREX Co.Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Vivozon Healthcare Inc
KQ:082800
-0.055x
Fountaine Pajo
PA:ALFPC
-0.038x
Jinzhou Port Co Ltd A
SHG:600190
-22.872x
BBMG Corporation
F:9BM
0.032x
Paragon Care Ltd
AU:PGC
-0.088x
Stellar V Capital Corp. Class A Ordinary Shares
NASDAQ:SVCC
-0.001x
Athens Medical C.S.A.
AT:IATR
0.029x
Dividend 15 Split Corp II
TO:DF
-0.012x

Annual Cash Flow Conversion Efficiency for NOVAREX Co.Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of NOVAREX Co.Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is NOVAREX Co.Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩254.64 Billion
≈ $172.57 Million
₩16.65 Billion
≈ $11.28 Million
0.065x +8.25%
2024-12-31 ₩220.26 Billion
≈ $149.27 Million
₩13.31 Billion
≈ $9.02 Million
0.060x -52.15%
2023-12-31 ₩200.42 Billion
≈ $135.82 Million
₩25.30 Billion
≈ $17.15 Million
0.126x +13.88%
2022-12-31 ₩181.37 Billion
≈ $122.91 Million
₩20.11 Billion
≈ $13.63 Million
0.111x -35.83%
2021-12-31 ₩139.67 Billion
≈ $94.65 Million
₩24.13 Billion
≈ $16.35 Million
0.173x +22.84%
2020-12-31 ₩115.61 Billion
≈ $78.35 Million
₩16.26 Billion
≈ $11.02 Million
0.141x +1093.29%
2019-12-31 ₩91.79 Billion
≈ $62.21 Million
₩-1.30 Billion
≈ $-880.82K
-0.014x -115.01%
2018-12-31 ₩78.93 Billion
≈ $53.49 Million
₩7.44 Billion
≈ $5.04 Million
0.094x -53.95%
2017-12-31 ₩51.88 Billion
≈ $35.16 Million
₩10.62 Billion
≈ $7.20 Million
0.205x +23.86%
2016-12-31 ₩44.62 Billion
≈ $30.24 Million
₩7.38 Billion
≈ $5.00 Million
0.165x -31.13%
2015-12-31 ₩36.31 Billion
≈ $24.61 Million
₩8.72 Billion
≈ $5.91 Million
0.240x --

About NOVAREX Co.Ltd

KQ:194700 Korea Packaged Foods
Market Cap
$163.99 Million
₩241.99 Billion KRW
Market Cap Rank
#17400 Global
#710 in Korea
Share Price
₩13670.00
Change (1 day)
-2.91%
52-Week Range
₩11940.00 - ₩22000.00
All Time High
₩23604.80
About

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more